INM·457637700·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
INM (INMED PHARMACEUTICALS INC) is held by 4 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($30,293), UBS Group AG ($5,204), Virtu Financial LLC ($13). Net institutional sentiment: Mixed.
See how INM's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer